Navigation Links
Independent Data Monitoring Committee Recommends Early Stopping of Phase 3 Study of Ibrutinib in Relapsed/Refractory CLL/SLL Patients Based on a Planned Interim Analysis
Date:1/7/2014

ost frequent adverse reaction leading to treatment discontinuation was subdural hematoma (1.8%). Adverse reactions leading to dose reduction occurred in 14% of patients.

Drug Interactions:

CYP3A Inhibitors – Avoid concomitant administration with strong or moderate inhibitors of CYP3A. If a moderate CYP3A inhibitor must be used, reduce the IMBRUVICA dose.

CYP3A Inducers – Avoid co-administration with strong CYP3A inducers.

Special Populations – Hepatic Impairment – Avoid use in patients with baseline hepatic impairment.

For the full prescribing information, visit http://www.imbruvica.com/downloads/Prescribing_Information.pdf

Ibrutinib has been submitted to the European Medicines Agency (EMA) for the treatment of adult patients with relapsed or CLL/SLL or adult patients with relapsed or refractory MCL. Use of ibrutinib in markets and for indications in which it has not been approved is investigational.

Ibrutinib is being jointly developed and commercialized by Janssen and Pharmacyclics, Inc. Pharmacyclics sponsored the study.

For more information, visit www.IMBRUVICA.com.

About Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia (CLL) is a slow-growing cancer of the white blood cells (lymphocytes), most commonly B cells. CLL is the most common adult leukemia. Small Lymphocytic Lymphoma (SLL) is a slow-growing lymphoma in which too many immature white blood cells cause lymph nodes to become larger than normal.

About Janssen Research & Development, LLC

At Janssen, we are dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Driven by our
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Hologic Expands its Board of Directors with Appointment of Two Independent Directors and Engages Chairman of Mt. Sinai Radiology Department as Scientific Advisor
2. Actinium Pharmaceuticals Appoints Richard Steinhart As New Independent Director
3. Leica Biosystems Launches Independently* Qualified Menu of IHC Antibodies for Hematopathology
4. American Pacific Board Continues Focus On Corporate Governance With Appointment Of Independent Lead Director
5. Independent Pharmacy Cooperative to Distribute Promescent, Topical Medication for Premature Ejaculation
6. Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
7. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
8. Managed Health Care Associates, Inc. (MHA) Released Results of Sixth Annual Independent Long Term Care Member Study with Expanded Specialty Pharmacy Findings
9. Agnitio Launches Rainmaker One to Remove the Complexity of Managing Independent Apps
10. Independent Drugstore Lobby Wants Sweeping Antitrust Exemptions to Charge Higher Prescription Drug Prices
11. Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... FRANCISCO , Oct. 30, 2014  Nektar Therapeutics ... results for the third quarter ended September 30, 2014 ... U.S.-based financial markets. Howard Robin , president and ... review the results beginning at 5:00 p.m. Eastern Time ... press release and a live audio-only Webcast of the ...
(Date:10/30/2014)... , Oct. 30, 2014  CytRx Corporation ... and development company specializing in oncology, today announced ... its lead drug candidate, aldoxorubicin.  The presentation, titled, ... Approach," will be given by Sant P. ... Oncology Center and principal investigator of the Company,s ...
(Date:10/30/2014)... -- , Extensively hydrolyzed milk formula with LGG ... Cow milk protein allergy (CMPA) is the leading cause of food ... has been managed by eliminating milk proteins from a ... is possible to help build of oral tolerance to ... the first year of life by using an extensively ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4Experts Present Latest Research at Allergy Day 2Experts Present Latest Research at Allergy Day 3
... SUNNYVALE, Calif. , April 23 Accuray ... today that French and Italian Health Authorities recently ruled that ... and the Lombardy region of Italy ... These decisions demonstrate the increasing recognition amongst European Health Authorities ...
... PRO-DEX, INC. (Nasdaq: PDEX ) will announce results for the ... 2010 on Thursday, April 29, 2010 after the market closes. ... Following the release, Pro-Dex will ... Pacific Time ) to discuss operating performance for the quarter.  Mark Murphy, Chief ...
Cached Medicine Technology:CyberKnife Radiosurgery Now Reimbursed Throughout France and Largest Italian Region 2CyberKnife Radiosurgery Now Reimbursed Throughout France and Largest Italian Region 3CyberKnife Radiosurgery Now Reimbursed Throughout France and Largest Italian Region 4Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast 2Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast 3
(Date:10/30/2014)... 2014 Timothy, InstaKNOT’s 4-year-old ... firefighters, showing that you are never too young to ... firefighters Tracey and Carl at the 2013 Santa Arriving ... Pompano Beach Chamber of Commerce. Tracey gave Timothy a ... Timothy wear his real fireman’s hat, and extending an ...
(Date:10/30/2014)... 2014 Don Allred Insurance, a leading ... plans for North Carolina residents, is excited to announce ... Holly Hill Mall. The new branch has been up ... customers through all facets of the insurance selection process ... spokesman Scott Allred couldn’t be happier with the timing ...
(Date:10/30/2014)... Portland, OR (PRWEB) October 30, 2014 ... law firm Hodgkinson Street LLC announces new branding ... Hodgkinson Street Mepham . After David Mepham’s promotion ... revitalizes their brand and website to include Mepham’s name ... leading medical malpractice and mediation firm, the decision to ...
(Date:10/30/2014)... 2014 Paramount Rx, a full-service prescription ... efforts to help people save money through its innovative ... for prescription drugs in the new health care system, ... to bridge the relationship between consumers, businesses and the ... challenges people face today with medical costs is the ...
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, Oct. ... with prostate cancer who also have certain heart problems may ... new study suggests. , , The therapy in question is called ... reduce levels of male hormones to prevent the growth of ... research, this hormone therapy was linked to triple the risk ...
Breaking Medicine News(10 mins):Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 3Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 4Health News:Allred Insurance Satellite Office Grand Opening 2Health News:Hodgkinson Street Mepham Rebrands 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 2Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 3
... Kathleen Doheny HealthDay Reporter , MONDAY, March 19 ... spectrum disorders earn significantly less than what mothers of children ... has found. These moms even earn less than mothers ... with autism earned, on average, less than $21,000 a year, ...
... clearer understanding of glaucoma | Back to top , Glaucoma ... blindness worldwide. In glaucoma patients, the optic nerve, which relays ... the molecular cause of nerve damage is unclear. Dr. Simon ... to understand the earliest events that lead to optic nerve ...
... American children leaving doctors, offices with an attention deficit ... 10 years, according to a new Northwestern Medicine study. ... physicians, have begun treating an increasing number of these ... which was published in the March/April issue of the ...
... HealthDay Reporter , MONDAY, March 19 (HealthDay ... cholesterol, might reduce a bit the risk of developing ... from a large international study that looked at the ... trial included almost 18,000 adults aged 50 or older ...
... University of Granada researchers have developed a software tool ... a person has to suffer a heart disease. In ... risk estimations, i.e. it helps estimating the risk that ... condition. The researchers employed a sample including 3 000 patients. ...
... , SUNDAY, March 18 (HealthDay News) -- Varicose ... can be a sign of a serious medical problem for ... Americans have varicose veins, and about 6 percent have more ... Peter Gloviczki, a vascular surgeon at the Mayo Clinic in ...
Cached Medicine News:Health News:Mothers of Kids With Autism Earn Less, Study Shows 2Health News:Mothers of Kids With Autism Earn Less, Study Shows 3Health News:JCI early table of contents for March 19, 2012 2Health News:JCI early table of contents for March 19, 2012 3Health News:JCI early table of contents for March 19, 2012 4Health News:JCI early table of contents for March 19, 2012 5Health News:JCI early table of contents for March 19, 2012 6Health News:JCI early table of contents for March 19, 2012 7Health News:JCI early table of contents for March 19, 2012 8Health News:JCI early table of contents for March 19, 2012 9Health News:Diagnosis of ADHD on the rise 2Health News:Could Statins Help Prevent Pneumonia? 2Health News:Could Statins Help Prevent Pneumonia? 3Health News:Scientists develop a software tool for estimating heart disease risk 2
Budde tapered retractor blade set....
Mini-Vise....
Permanently sharp, slightly angulated blade, delicate sharp dissection, excellent balanced, ergonomic design....
Cone Ring Curettes, length 9" (229 mm), ring diameter (I.D.) 5/16" (8 mm)....
Medicine Products: